Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate status.

Wirth C, Schubert F, Lautenschlager M, Brühl R, Klär A, Majic T, Lang UE, Ehrlich A, Winterer G, Sander T, Schouler-Ocak M, Gallinat J.

Curr Pharm Biotechnol. 2012 Jun;13(8):1513-21.

PMID:
22283763
[PubMed - indexed for MEDLINE]
2.

DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients--support for the glutamate hypothesis of schizophrenias.

Fallgatter AJ, Ehlis AC, Herrmann MJ, Hohoff C, Reif A, Freitag CM, Deckert J.

Genes Brain Behav. 2010 Jul;9(5):489-97. doi: 10.1111/j.1601-183X.2010.00574.x. Epub 2010 Feb 17.

PMID:
20180862
[PubMed - indexed for MEDLINE]
3.

The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.

Trost S, Platz B, Usher J, Scherk H, Wobrock T, Ekawardhani S, Meyer J, Reith W, Falkai P, Gruber O.

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):53-63. doi: 10.1007/s00406-012-0320-0. Epub 2012 May 13.

PMID:
22580710
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.

Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS.

Neurosci Lett. 2006 Oct 23;407(2):101-6. Epub 2006 Sep 7.

PMID:
16959423
[PubMed - indexed for MEDLINE]
5.

Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.

Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, Ozaki N, Taguchi T, Tatsumi M, Kamijima K, Straub RE, Weinberger DR, Kunugi H, Hashimoto R.

Hum Mol Genet. 2004 Nov 1;13(21):2699-708. Epub 2004 Sep 2.

PMID:
15345706
[PubMed - indexed for MEDLINE]
Free Article
6.

Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.

Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, Weinberger DR, Kleinman JE.

Arch Gen Psychiatry. 2004 Jun;61(6):544-55.

PMID:
15184234
[PubMed - indexed for MEDLINE]
7.

DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals.

Fallgatter AJ, Herrmann MJ, Hohoff C, Ehlis AC, Jarczok TA, Freitag CM, Deckert J.

Neuropsychopharmacology. 2006 Sep;31(9):2002-10. Epub 2006 Jan 11.

PMID:
16407900
[PubMed - indexed for MEDLINE]
Free Article
8.

Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex.

Gallinat J, Schubert F, Brühl R, Hellweg R, Klär AA, Kehrer C, Wirth C, Sander T, Lang UE.

Neuroimage. 2010 Jan 1;49(1):767-71. doi: 10.1016/j.neuroimage.2009.08.018. Epub 2009 Aug 13.

PMID:
19683059
[PubMed - indexed for MEDLINE]
9.

Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.

Pae CU, Serretti A, Mandelli L, Yu HS, Patkar AA, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH, Kim JJ.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jul 5;144B(5):701-3.

PMID:
17192893
[PubMed - indexed for MEDLINE]
10.

Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.

Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP.

Eur Psychiatry. 2010 Oct;25(6):314-9. doi: 10.1016/j.eurpsy.2009.11.011. Epub 2010 Jul 7.

PMID:
20615671
[PubMed - indexed for MEDLINE]
11.

Regional cerebral glutamate concentrations and chronic tobacco consumption.

Gallinat J, Schubert F.

Pharmacopsychiatry. 2007 Mar;40(2):64-7.

PMID:
17447175
[PubMed - indexed for MEDLINE]
12.

The impact of blood pressure on hippocampal glutamate and mnestic function.

Westhoff TH, Schubert F, Wirth C, Joppke M, Klär AA, Zidek W, Gallinat J.

J Hum Hypertens. 2011 Apr;25(4):256-61. doi: 10.1038/jhh.2010.51. Epub 2010 May 13.

PMID:
20463749
[PubMed - indexed for MEDLINE]
13.

Effects of DTNBP1 genotype on brain development in children.

Tognin S, Viding E, McCrory EJ, Taylor L, O'Donovan MC, McGuire P, Mechelli A.

J Child Psychol Psychiatry. 2011 Dec;52(12):1287-94. doi: 10.1111/j.1469-7610.2011.02427.x. Epub 2011 Jun 3.

PMID:
21639861
[PubMed - indexed for MEDLINE]
14.

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.

van Elst LT, Valerius G, Büchert M, Thiel T, Rüsch N, Bubl E, Hennig J, Ebert D, Olbrich HM.

Biol Psychiatry. 2005 Nov 1;58(9):724-30. Epub 2005 Jul 14.

PMID:
16018980
[PubMed - indexed for MEDLINE]
15.

A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia.

Voisey J, Swagell CD, Hughes IP, Connor JP, Lawford BR, Young RM, Morris CP.

Behav Brain Funct. 2010 Jul 9;6:41. doi: 10.1186/1744-9081-6-41.

PMID:
20615259
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals.

Markov V, Krug A, Krach S, Jansen A, Eggermann T, Zerres K, Stöcker T, Shah NJ, Nöthen MM, Treutlein J, Rietschel M, Kircher T.

Hum Brain Mapp. 2010 Feb;31(2):266-75. doi: 10.1002/hbm.20862.

PMID:
19650139
[PubMed - indexed for MEDLINE]
17.

Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.

Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC.

Neuropsychopharmacology. 2012 Nov;37(12):2635-42. doi: 10.1038/npp.2012.126. Epub 2012 Jul 18.

PMID:
22805603
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Dysbindin (DTNBP1)--a role in psychotic depression?

Domschke K, Lawford B, Young R, Voisey J, Morris CP, Roehrs T, Hohoff C, Birosova E, Arolt V, Baune BT.

J Psychiatr Res. 2011 May;45(5):588-95. doi: 10.1016/j.jpsychires.2010.09.014. Epub 2010 Oct 15.

PMID:
20951386
[PubMed - indexed for MEDLINE]
19.

Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.

Tochigi M, Zhang X, Ohashi J, Hibino H, Otowa T, Rogers M, Kato T, Okazaki Y, Kato N, Tokunaga K, Sasaki T.

Neurosci Res. 2006 Oct;56(2):154-8. Epub 2006 Jul 31.

PMID:
16876895
[PubMed - indexed for MEDLINE]
20.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk